Among these, B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) stand as the prevailing biomarkers applied in the prognostic assessment of individuals afflicted with heart failure. This evidence concerns the gene NPPB and heart failure.